Login / Signup

Validation in type 2 diabetes of a metabolomic signature of all-cause mortality.

Massimiliano CopettiMarco Giorgio BaroniRaffaella BuzzettiMaria Gisella CavalloEfiso CossuPaola D'AngeloSalvatore De CosmoFrida LeonettiSusanna MoranoLelio MorviducciNicola NapoliSabrina PrudenteGiuseppe PuglieseAntonio Fernando SavinoVincenzo Trischitta
Published in: Diabetes/metabolism research and reviews (2023)
The metabolomic signature of mortality in the general population is only partially effective in type 2 diabetes. Prediction markers developed and validated in the general population must be revalidated if they are to be used in patients with diabetes.
Keyphrases
  • type diabetes
  • glycemic control
  • cardiovascular disease
  • insulin resistance
  • cardiovascular events
  • risk factors
  • adipose tissue
  • metabolic syndrome